ZA200606687B - Oxydecahydronaphthalene modulators of HM74 - Google Patents
Oxydecahydronaphthalene modulators of HM74Info
- Publication number
- ZA200606687B ZA200606687B ZA200606687A ZA200606687A ZA200606687B ZA 200606687 B ZA200606687 B ZA 200606687B ZA 200606687 A ZA200606687 A ZA 200606687A ZA 200606687 A ZA200606687 A ZA 200606687A ZA 200606687 B ZA200606687 B ZA 200606687B
- Authority
- ZA
- South Africa
- Prior art keywords
- oxydecahydronaphthalene
- modulators
- oxydecahydronaphthalene modulators
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pyrane Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54601204P | 2004-02-20 | 2004-02-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200606687B true ZA200606687B (en) | 2008-02-27 |
Family
ID=34910747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200606687A ZA200606687B (en) | 2004-02-20 | 2006-08-11 | Oxydecahydronaphthalene modulators of HM74 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7264937B2 (xx) |
| EP (1) | EP1718293A1 (xx) |
| JP (1) | JP2007526917A (xx) |
| KR (1) | KR101145693B1 (xx) |
| CN (1) | CN1929833A (xx) |
| AR (1) | AR047708A1 (xx) |
| AU (1) | AU2005216878B2 (xx) |
| BR (1) | BRPI0507916A (xx) |
| CA (1) | CA2556757C (xx) |
| CR (1) | CR8537A (xx) |
| EC (1) | ECSP066776A (xx) |
| IL (1) | IL177106A (xx) |
| MA (1) | MA28368A1 (xx) |
| ME (2) | ME00059B (xx) |
| NO (1) | NO20064214L (xx) |
| RS (1) | RS20060472A (xx) |
| RU (1) | RU2006133539A (xx) |
| TN (1) | TNSN06235A1 (xx) |
| TW (1) | TWI354552B (xx) |
| WO (1) | WO2005082352A1 (xx) |
| ZA (1) | ZA200606687B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7094572B2 (en) * | 2003-03-14 | 2006-08-22 | Bristol-Myers Squibb | Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 |
| AU2005311930B9 (en) | 2004-12-03 | 2009-09-10 | Merck Sharp & Dohme Corp. | Substituted piperazines as CB1 antagonists |
| BRPI0706623A2 (pt) * | 2006-01-18 | 2011-04-12 | Schering Corp | moduladores de receptor canabinóide |
| US20100197564A1 (en) * | 2007-04-19 | 2010-08-05 | Schering Corporation | Diaryl morpholines as cb1 modulators |
| AU2008271178A1 (en) * | 2007-06-28 | 2009-01-08 | Intervet International B.V. | Substituted piperazines as CB1 antagonists |
| CN101790521A (zh) * | 2007-06-28 | 2010-07-28 | 英特维特国际股份有限公司 | 作为cb1拮抗剂的取代哌嗪 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5674908A (en) * | 1993-12-20 | 1997-10-07 | Life Technologies, Inc. | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| DE19624154A1 (de) * | 1996-06-18 | 1998-01-08 | Hoechst Ag | Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung |
| US6555339B1 (en) | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
| AU7966098A (en) * | 1997-06-12 | 1998-12-30 | Smithkline Beecham Corporation | Hm74a receptor |
| GB0021484D0 (en) * | 2000-09-01 | 2000-10-18 | Boehringer Ingelheim Pharma | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
-
2005
- 2005-02-10 WO PCT/US2005/004095 patent/WO2005082352A1/en not_active Ceased
- 2005-02-10 AU AU2005216878A patent/AU2005216878B2/en not_active Ceased
- 2005-02-10 EP EP05713199A patent/EP1718293A1/en not_active Withdrawn
- 2005-02-10 RU RU2006133539/04A patent/RU2006133539A/ru not_active Application Discontinuation
- 2005-02-10 CN CNA2005800075098A patent/CN1929833A/zh active Pending
- 2005-02-10 BR BRPI0507916-0A patent/BRPI0507916A/pt active Search and Examination
- 2005-02-10 ME MEP-2008-170A patent/ME00059B/me unknown
- 2005-02-10 KR KR1020067016693A patent/KR101145693B1/ko not_active Expired - Fee Related
- 2005-02-10 CA CA2556757A patent/CA2556757C/en not_active Expired - Fee Related
- 2005-02-10 ME MEP-170/08A patent/MEP17008A/xx unknown
- 2005-02-10 JP JP2006554127A patent/JP2007526917A/ja active Pending
- 2005-02-10 RS RSP-2006/0472A patent/RS20060472A/sr unknown
- 2005-02-14 US US11/057,263 patent/US7264937B2/en not_active Expired - Lifetime
- 2005-02-18 AR ARP050100595A patent/AR047708A1/es unknown
- 2005-02-18 TW TW094104732A patent/TWI354552B/zh not_active IP Right Cessation
-
2006
- 2006-07-26 IL IL177106A patent/IL177106A/en not_active IP Right Cessation
- 2006-07-26 CR CR8537A patent/CR8537A/es not_active Application Discontinuation
- 2006-07-28 TN TNP2006000235A patent/TNSN06235A1/en unknown
- 2006-08-11 ZA ZA200606687A patent/ZA200606687B/xx unknown
- 2006-08-18 EC EC2006006776A patent/ECSP066776A/es unknown
- 2006-08-24 MA MA29288A patent/MA28368A1/fr unknown
- 2006-09-18 NO NO20064214A patent/NO20064214L/no not_active Application Discontinuation
-
2007
- 2007-08-30 US US11/847,370 patent/US20080045586A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1929833A (zh) | 2007-03-14 |
| IL177106A0 (en) | 2006-12-10 |
| US20050187263A1 (en) | 2005-08-25 |
| MA28368A1 (fr) | 2006-12-01 |
| NO20064214L (no) | 2006-09-18 |
| ECSP066776A (es) | 2006-11-16 |
| BRPI0507916A (pt) | 2007-07-10 |
| TNSN06235A1 (en) | 2007-12-03 |
| TWI354552B (en) | 2011-12-21 |
| KR101145693B1 (ko) | 2012-05-25 |
| WO2005082352A1 (en) | 2005-09-09 |
| AR047708A1 (es) | 2006-02-08 |
| ME00059B (me) | 2010-06-10 |
| JP2007526917A (ja) | 2007-09-20 |
| CR8537A (es) | 2007-03-05 |
| KR20060127982A (ko) | 2006-12-13 |
| CA2556757C (en) | 2011-05-03 |
| RS20060472A (sr) | 2008-11-28 |
| IL177106A (en) | 2012-03-29 |
| AU2005216878A1 (en) | 2005-09-09 |
| AU2005216878B2 (en) | 2010-06-17 |
| CA2556757A1 (en) | 2005-09-09 |
| MEP17008A (hr) | 2010-06-10 |
| US20080045586A1 (en) | 2008-02-21 |
| RU2006133539A (ru) | 2008-03-27 |
| EP1718293A1 (en) | 2006-11-08 |
| US7264937B2 (en) | 2007-09-04 |
| TW200539864A (en) | 2005-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0420719D0 (en) | Novel allosteric modulators | |
| GB0420722D0 (en) | Novel allosteric modulators | |
| PT1802579E (pt) | Derivados da 3-arilaminopiridina | |
| IL178290A0 (en) | Tetrahydro-indazole cannabinoid modulators | |
| IL232540A (en) | Factor-site change of viii | |
| IL178029A0 (en) | Use of sulfonylureas | |
| PT1778618E (pt) | Síntese de trietilenotetraminas | |
| PL1737304T3 (pl) | Zagęszczona płynna formuła | |
| EP1928489A4 (en) | Ghrelin Analogs | |
| GB0403889D0 (en) | Uses of er-beta modulators | |
| EP1711484A4 (en) | SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES | |
| IL177106A0 (en) | Oxydecahydronaphthalene modulators of hm74 | |
| IL172276A0 (en) | Cross-reference to related application | |
| EP1721158A4 (en) | MODULATORS OF ANGIOGENESIS | |
| AU158223S (en) | Wristwatch | |
| EP1831204A4 (en) | COMPOUNDS AMBRUTICINE VS | |
| IL178184A0 (en) | Synthesis of pyrrole-2-carbonitriles | |
| GB0510501D0 (en) | Display of operational instructions | |
| GB0427954D0 (en) | Modulator | |
| EP1827482A4 (en) | NEW USES OF EGF | |
| GB0420721D0 (en) | Novel allosteric modulators | |
| GB0422748D0 (en) | Novel allosteric modulators | |
| GB0401130D0 (en) | Modulators | |
| IL179559A0 (en) | Theramutein modulators | |
| GB0401131D0 (en) | Modulators |